Baird initiated coverage of Coherus Biosciences with an Outperform rating and $11 price target.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CHRS:
- Coherus Biosciences price target lowered to $11 from $14 at Citi
- Coherus Biosciences cut to Hold at Maxim on slow start for Yusimry
- Coherus Biosciences downgraded to Hold from Buy at Maxim
- Coherus Biosciences price target lowered to $12 from $20 at Truist
- Coherus Biosciences price target lowered to $13 from $20 at H.C. Wainwright
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue